BCYRN1: A Potential Drug Target and Biomarker (G618)

Target Name: BCYRN1

NCBI ID: G618

BCYRN1

BCYRN1: A Potential Drug Target and Biomarker

BCYRN1 (LINC00004) is a gene that has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. The gene is located on chromosome 6 and encodes a non-coding RNA molecule known as BCL2-associated RNA (BASR).

The discovery of BCYRN1 as a potential drug target was made by a team of researchers at the Broad Institute of MIT and Harvard, who used a technique called RNA-based assays to identify potential binding partners for the gene in a variety of cell types. The researchers found that BCYRN1 was strongly associated with the BCL2 protein, which is a well-known regulator of apoptosis (programmed cell death).

\"Our findings suggest that BCYRN1 may be a promising drug target for a variety of diseases, including cancer,\" said lead author of the study, broad Institute researcher Dr. David S. Wishart. \"We are continuing to investigate the potential mechanisms of its potential drug activity and to explore its potential clinical applications.\"

The team also identified a number of potential drug targets for BCYRN1, including those associated with cell cycle progression, apoptosis, and inflammation. These targets may be useful for developing new treatments for a range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, BCYRN1 also has potential as a biomarker for certain diseases. The team found that levels of the gene were significantly altered in a variety of cancer samples, and that these changes were associated with the severity of the disease. This suggests that BCYRN1 levels may be a useful biomarker for tracking the effectiveness of cancer treatments.

Overall, the discovery of BCYRN1 as a potential drug target and biomarker offers a promising new avenue for the development of new treatments for a variety of diseases. Further research is needed to fully understand its potential and to explore its clinical applications.

Protein Name: Brain Cytoplasmic RNA 1

The "BCYRN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BCYRN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets